US Patent 10067135 Multiplex hepatitis B assay
Patent 10067135 was granted and assigned to Bio-Rad Laboratories on September, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
Provided herein are multiplex assays for determining whether an individual is or has been infected with Hepatitis B virus, and the stage of infection or resolution. In addition, the multiplex system can discriminate between vaccinated subjects and subjects susceptible to Hepatitis B infection.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Ravi Kaul0
Roger Walker0
Weiming Zheng0
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100671350
Date of Patent
September 4, 2018
0Patent Application Number
158970400
Date Filed
February 14, 2018
0Patent Primary Examiner
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10067135 Multiplex hepatitis B assay
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10067135
Date of patent
September 4, 2018
Patent application number
15897040
Date Filed
February 14, 2018
Patent primary examiner
Find more entities like US Patent 10067135 Multiplex hepatitis B assay
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
